wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37278239-50926A59-115F-4DD7-8884-BA7EC073170F
Q37278239-50926A59-115F-4DD7-8884-BA7EC073170F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37278239-50926A59-115F-4DD7-8884-BA7EC073170F
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial
P2860
Q37278239-50926A59-115F-4DD7-8884-BA7EC073170F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37278239-50926A59-115F-4DD7-8884-BA7EC073170F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83d33598437f89c0342409254c3a22393abe4cea
P2860
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.